Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: KínaFázis nélkül

Exploration of Brain Functional Networks in Patients With Hidradenitis Suppurativa Using fMRI

A legfontosabb adatok

Ki végzi
Second Xiangya Hospital of Central South University
Hol
Changsha (Kína)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
80 fő, tervezett
Kezdés
2026. jan. 3.
Várható befejezés
2027. jan.
A vizsgálat típusa
Megfigyeléses, 3 csoport
A vizsgált kezelések
  • Routine Biologic Therapy for Hidradenitis Suppurativa
A regiszteradat frissítve
2026. augusztus 10.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with hidradenitis suppurativa (HS), a long-lasting skin disease with painful lumps, and healthy adults for comparison. It studies resting brain activity with MRI scans.

Életkor
People with HS: 18 to 45 years. Healthy participants: 18 to 55 years.
Nem
All sexes can join.
A betegség stádiuma
People with HS must be diagnosed using standard clinical criteria. Healthy participants cannot have HS or another chronic skin disease. A subgroup with HS is due to start biologic or small-molecule treatment as part of their regular care.
Korábbi kezelés
People with HS cannot have used biologic or small-molecule therapy that may affect HS in the 3 months before joining.

A részvétel fő kizáró okai

  • Pregnancy or breastfeeding.
  • Current use of antidepressants or medicines that may make seizures more likely.
  • Schizophrenia, bipolar disorder or another major mental illness, or alcohol or drug abuse in the past 3 months.
  • Anything that rules out MRI, such as metal in the head, a pacemaker or fear of closed spaces.
  • People with HS who also have lupus, dermatomyositis, atopic dermatitis or other relevant skin diseases. All participants must be right-handed.

A regiszter feltételei, szó szerint

Mind a 28 feltétel megnézéseKevesebb

Ki vehet részt

  • For Participants With Hidradenitis Suppurativa:
  • Aged 18 to 45 years
  • Diagnosed with hidradenitis suppurativa according to established clinical diagnostic criteria
  • Able and willing to comply with the study procedures and follow-up assessments
  • Able to provide written informed consent and willing to permit photography of affected skin areas
  • No coexisting systemic lupus erythematosus, dermatomyositis, atopic dermatitis, steroid-dependent dermatitis, or other relevant skin diseases
  • No use of biologic or small-molecule therapy that may affect hidradenitis suppurativa symptoms within 3 months before enrollment
  • Right-handed according to the Edinburgh Handedness Inventory; For Healthy Participants:
  • Aged 18 to 55 years
  • No hidradenitis suppurativa or other chronic skin disease
  • No chronic pain disorder
  • No major neurological or psychiatric disorder
  • Right-handed according to the Edinburgh Handedness Inventory
  • Able to provide written informed consent and comply with the study procedures; For the Longitudinal Treatment Cohort:
  • Meets the eligibility criteria for participants with hidradenitis suppurativa
  • Is scheduled to receive biologic or small-molecule therapy for hidradenitis suppurativa as part of routine clinical care, as determined by the treating physician
  • Willing and able to complete assessments before treatment and during 3 months of follow-up

Ki nem vehet részt

  • Participation in another investigational drug study within 1 month before enrollment
  • Alcohol or drug abuse or dependence within the previous 3 months
  • Previous or current treatment with electroconvulsive therapy, vagus nerve stimulation, or transcranial magnetic stimulation
  • Current use of medications that may lower the seizure threshold or current use of antidepressant medication
  • Serious cardiac, hepatic, pulmonary, renal, thyroid, hematologic, or other systemic disease; malignant tumor; or another clinically significant abnormality that, in the investigator's judgment, makes participation inappropriate
  • Schizophrenia, bipolar disorder, or another major psychiatric disorder
  • A neurological condition that may interfere with participation or interpretation of the imaging results, including markedly elevated intracranial pressure, intracranial vascular lesions, impaired consciousness, or inability to cooperate with study procedures
  • Any contraindication to magnetic resonance imaging, including intracranial metallic foreign bodies, cardiac pacemakers, incompatible vascular or cardiac implants, or claustrophobia
  • Pregnancy or breastfeeding
  • Inability to remain still or comply with resting-state functional magnetic resonance imaging procedures
  • Unwillingness to allow study data to be collected

A fő feltételek kérdésként

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 18 és 45 év között vagy?

Helyszínek itt: Kína

  • Second Xiangya Hospital of Central South UniversityChangsha, KínaContact: Yi ZhanRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

The goal of this observational study is to learn whether adults with hidradenitis suppurativa (HS) have changes in resting brain activity and how these changes are related to disease severity, pain, sleep, mood, and quality of life. The study will also examine whether brain activity changes after patients receive biologic or small-molecule treatment as part of their regular medical care.

A teljes eredeti leírásKevesebb

The main questions it aims to answer are:

* Are resting brain activity patterns different between people with HS and healthy participants? * Are these brain activity patterns related to HS severity, pain, sleep problems, anxiety, depression, and quality of life? * Do brain activity patterns change after 3 months of routine treatment, and are these changes related to improvement in HS symptoms? Researchers will compare participants with HS with healthy participants of similar age and sex. A subgroup of participants with HS who receive biologic or small-molecule treatment as part of routine clinical care will also be assessed before and after treatment.

Participants may:

* Complete assessments of HS severity, pain, sleep, mood, and quality of life * Undergo resting-state functional magnetic resonance imaging * Undergo skin ultrasound and routine laboratory testing * Allow photographs of affected skin areas to be taken * Return for follow-up assessments for up to 3 months

A vizsgálat 3 csoportja

  • HS Cross-Sectional Cohort

    Adults with hidradenitis suppurativa who participate in the cross-sectional comparison with healthy participants. They will undergo baseline clinical assessments, questionnaires, skin ultrasound, laboratory testing, and resting-state functional magnetic resonance imaging.

  • HS Longitudinal Treatment Cohort

    A subgroup of adults with hidradenitis suppurativa who receive biologic or small-molecule therapy as part of routine clinical care. Participants will undergo assessments before treatment and during 3 months of follow-up, including repeat resting-state functional magnetic resonance imaging at month 3.

    Kezelés: Routine Biologic Therapy for Hidradenitis Suppurativa

  • Healthy Participants

    Age- and sex-matched healthy adults without hidradenitis suppurativa, other chronic skin diseases, chronic pain disorders, or major neurological or psychiatric disorders.

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
Kérdések a feltételekről
Forrás: NCT07755670: ki vehet részt
A regiszteradat frissítve
2026. augusztus 10.